DocuSign (DOCU) Reports Q4 Earnings: What Key Metrics Have to Say

13.03.25 22:30 Uhr

Werte in diesem Artikel

DocuSign (DOCU) reported $776.25 million in revenue for the quarter ended January 2025, representing a year-over-year increase of 9%. EPS of $0.86 for the same period compares to $0.76 a year ago.The reported revenue represents a surprise of +2.14% over the Zacks Consensus Estimate of $759.96 million. With the consensus EPS estimate being $0.84, the EPS surprise was +2.38%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how DocuSign performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Non-GAAP billings: $923.21 million compared to the $875.20 million average estimate based on six analysts. Total Customers: 1.7 million compared to the 1.67 million average estimate based on two analysts. Revenue- Professional services and other: $18.49 million versus the seven-analyst average estimate of $16.80 million. The reported number represents a year-over-year change of +10.7%. Revenue- Subscription: $757.77 million compared to the $743.15 million average estimate based on seven analysts. The reported number represents a change of +8.9% year over year. Non-GAAP subscription gross profit: $637.08 million versus the six-analyst average estimate of $620.78 million. Non-GAAP professional services and other gross profit: $1.59 million versus the five-analyst average estimate of -$1.33 million. View all Key Company Metrics for DocuSign here>>>Shares of DocuSign have returned -9.2% over the past month versus the Zacks S&P 500 composite's -7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Docusign Inc. (DOCU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: DocuSign und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf DocuSign

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DocuSign

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DocuSign Inc Registered Shs

Wer­bung

Analysen zu DocuSign Inc Registered Shs

DatumRatingAnalyst
13.02.2019DocuSign BuyDeutsche Bank AG
19.10.2018DocuSign NeutralWedbush Morgan Securities Inc.
22.05.2018DocuSign HoldDeutsche Bank AG
DatumRatingAnalyst
13.02.2019DocuSign BuyDeutsche Bank AG
DatumRatingAnalyst
19.10.2018DocuSign NeutralWedbush Morgan Securities Inc.
22.05.2018DocuSign HoldDeutsche Bank AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DocuSign Inc Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen